stars 1 stars 2 stars 3

Aíma develops advanced liquid biopsy tests for minimal residual disease and early cancer detection. Our whole-genome methylation and fragmentomics platform combines AI with ultra-sensitive sequencing to detect cancer DNA and determine its tissue of origin. We collaborate with leading clinical centers to bring faster, more accurate and more accessible cancer diagnostics to patients.

Website http://www.aima-diagnostics.com
Employees 7 (5 on RocketReach)
Founded 2025
Industry Pharmaceutical Manufacturing

Aíma Questions

Michael Blum is the Co-founder and CSO of Aíma.

5 people are employed at Aíma.

Aíma is based in Grenoble, Auvergne-Rhône-Alpes.

Top Aíma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users